Financial HealthSFZN's balance sheet is seen as healthy, which supports potential US expansion and merger or acquisition activities.
Market PositionSFZN is positioned to outperform peers due to its strong position in the generics market, especially against competitors facing higher tariffs.
Operational EfficiencyEBITDA margins are anticipated to increase, reflecting a positive outlook on operational efficiency.